Nicht-invasive Diagnostik der pulmonalen Hypertonie

Zusammenfassung

Die 2009 veröffentliche Europäischen Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie sind nunmehr auch in Deutschland gültig. Die Leitlinien befassen sich eingehend mit der Diagnostik der pulmonalen Hypertonie. Für die praktische Umsetzung der Europäischen Leitlinien in Deutschland sind jedoch zahlreiche spezifische Gesichtspunkte und neue Daten bedeutsam, die eine ausführliche Kommentierung der Leitlinien und in einigen Punkten eine Aktualisierung notwendig machen. Im Juni 2010 fand in Köln eine Konsensuskonferenz statt, die von den Arbeitsgruppen PH der Deutschen Gesellschaften für Kardiologie (DGK), Pneumologie (DGP) und Pädiatrische Kardiologie (DGPK) organisiert wurde. Die Konferenz befasste sich mit der Umsetzung der Europäischen Leitlinien in Deutschland. Dazu wurden verschiedene Arbeitsgruppen eingesetzt, von denen sich eine gezielt der nicht-invasiven Diagnostik der pulmonalen Hypertonie widmete. Die Ergebnisse und Beschlüsse dieser Arbeitsgruppe werden in dem vorliegenden Manuskript detailliert beschrieben.

Abstract

The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension have been adopted for Germany. The guidelines contain detailed recommendations for the diagnosis of pulmonary hypertension. However, the practical implementation of the European Guidelines in Germany requires the consideration of several country-specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update y appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to non-invasive diagnosis of PH. This commentary summarizes the results and recommendations of the working group on treatment of PAH.

Schlüsselwörter

pulmonale Hypertonie Diagnose

Keywords

pulmonary hypertension diagnosis

Literatur

• 1 Rich S, Dantzker D R, Ayres S M. et al . Primary pulmonary hypertension. A national prospective study.  Ann Intern Med. 1987;  107 216-223
• 2 Gaine S P, Rubin L J. Primary pulmonary hypertension.  Lancet. 1998;  352 719-725
• 3 Tongers J, Schwerdtfeger B, Klein G. et al . Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension.  Am Heart J. 2007;  153 127-132
• 4 Hoeper M M, Pletz M W, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension.  Eur Respir J. 2007;  29 944-950
• 5 Badesch D B, Champion H C, Sanchez M A. et al . Diagnosis and assessment of pulmonary arterial hypertension.  J Am Coll Cardiol. 2009;  54 S55-66
• 6 Fisher M R, Criner G J, Fishman A P. et al . Estimating pulmonary artery pressures by echocardiography in patients with emphysema.  Eur Respir J. 2007;  30 914-921
• 7 Hachulla E, Gressin V, Guillevin L. et al . Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.  Arthritis Rheum. 2005;  52 3792-3800
• 8 Mukerjee D, St George D, Knight C. et al . Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.  Rheumatology. 2004;  43 461-466
• 9 Launay D, Mouthon L, Hachulla E. et al . Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.  J Rheumatol. 2007;  34 1005-1011
• 10 Sitbon O, Lascoux-Combe C, Delfraissy J F. et al . Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.  Am J Respir Crit Care Med. 2008;  177 108-113
• 11 Rudski L G, Lai W W, Afilalo J. et al . Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.  J Am Soc Echocardiogr. 2010;  23 685-713; 786 – 788
• 12 Bonderman D, Wexberg P, Martischnig A. et al . A non-invasive algorithm to exclude precapillary pulmonary hypertension.  Eur Respir J. 2010 in press; 
• 13 Tunariu N, Gibbs S J, Win Z. et al . Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension.  J Nucl Med. 2007;  48 680-684
• 14 Resten A, Maitre S, Humbert M. et al . Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease.  Am J Roentgenol. 2004;  183 65-70
• 15 Dartevelle P, Fadel E, Mussot S. et al . Chronic thromboembolic pulmonary hypertension.  Eur Respir J. 2004;  23 637-648
• 16 Reichelt A, Hoeper M M, Galanski M. et al . Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angio-graphy.  Eur J Radiol. 2009;  71 49-54
• 17 Fedullo P F, Auger W R, Kerr K M. et al . Chronic thromboembolic pulmonary hypertension.  N Engl J Med. 2001;  345 1465-1472
• 18 Marcus J T, Gan C T, Zwanenburg J J. et al . Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling.  J Am Coll Cardiol. 2008;  51 750-757
• 19 Torbicki A. Cardiac magnetic resonance in pulmonary arterial hypertension, a step in the right direction.  Eur Heart J. 2007;  28 1187-1189
• 20 Rich S, Kieras K, Groves B. et al . Antinuclear antibodies in primary pulmonary hypertension.  J Am Coll Cardiol. 1986;  8 1307-1311
• 21 Chu J W, Kao P N, Faul J L. et al . High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension.  Chest. 2002;  122 1668-1673
• 22 Albrecht T, Blomley M J, Cosgrove D O. et al . Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent.  Lancet. 1999;  353 1579-1583
• 23 Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension.  Swiss Med Wkly. 2003;  133 163-169
• 24 D’Alonzo G E, Barst R J, Ayres S M. et al . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.  Ann Intern Med. 1991;  115 343-349
• 25 Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS ATS statement: Guidelines for the six minute walk test.  Am J Respir Crit Care Med. 2002;  166 111-117
• 26 Miyamoto S, Nagaya N, Satoh T. et al . Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.  Am J Respir Crit Care Med. 2000;  161 487-492
• 27 Sitbon O, Humbert M, Nunes H. et al . Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.  J Am Coll Cardiol. 2002;  40 780-788
• 28 Paciocco G, Martinez F, Bossone E. et al . Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension.  Eur Respir J. 2001;  17 647-652
• 29 Oudiz R J, Barst R J, Hansen J E. et al . Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.  Am J Cardiol. 2006;  97 123-126
• 30 Wensel R, Opitz C F, Anker S D. et al . Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.  Circulation. 2002;  106 319-324
• 31 Ross R M. ATS/ACCP statement on cardiopulmonary exercise testing.  Am J Respir Crit Care Med. 2003;  167 1451
• 32 Palange P, Ward S A, Carlsen K H. et al . Recommendations on the use of exercise testing in clinical practice.  Eur Respir J. 2007;  29 185-209
• 33 Yasunobu Y, Oudiz R J, Sun X G. et al . End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension.  Chest. 2005;  127 1637-46
• 34 Tolle J J, Waxman A B, Van Horn T L. et al . Exercise-induced pulmonary arterial hypertension.  Circulation. 2008;  118 2183-2189
• 35 Sun X G, Hansen J E, Oudiz R J, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension.  Circulation. 2001;  104 429-435
• 36 Groepenhoff H, Vonk-Noordegraaf A, Boonstra A. et al . Exercise testing to estimate survival in pulmonary hypertension.  Med Sci Sports Exerc. 2008;  40 1725-1732
• 37 Bonow R O, Carabello B A, Kanu C. et al . ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.  Circulation. 2006;  114 e84-231
• 38 Kovacs G, Maier R, Aberer E. et al . Assessment of pulmonary arteriel pressure during exercise in collagen vascular disease: echocardiography versus right heart catheterisation (in press).  Chest. 2010; in press; 
• 39 Himelman R B, Stulbarg M, Kircher B. et al . Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.  Circulation. 1989;  79 863-871
• 40 Argiento P, Chesler N, Mule M. Exercise stress echocardiography for the study of the pulmonary circulation.  Eur Respir J. 2010;  35 1273-1278
• 41 Grunig E, Weissmann S, Ehlken N. et al . Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.  Circulation. 2009;  119 1747-1757
• 42 Grunig E, Janssen B, Mereles D. et al . Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene.  Circulation. 2000;  102 1145-1150
• 43 Alkotob M L, Soltani P, Sheatt M A. et al . Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma.  Chest. 2006;  130 176-181
• 44 Collins N, Bastian B, Quiqueree L. et al . Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: Pulmonary Hypertension Assessment and Screening Evaluation using stress echocardiography (PHASE-I).  Eur J Echocardiogr. 2006;  7 439-446
• 45 Pignone A, Mori F, Pieri F. et al . Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis.  Ann N Y Acad Sci. 2007;  1108 291-304
• 46 Callejas-Rubio J L, Moreno-Escobar E, de la Fuente P M. et al . Prevalence of exercise pulmonary arterial hypertension in scleroderma.  J Rheumatol. 2008;  35 1812-1816
• 47 Steen V, Chou M, Shanmugam V. et al . Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.  Chest. 2008;  134 146-151
• 48 Condliffe R, Kiely D G, Peacock A J. et al . Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.  Am J Respir Crit Care Med. 2009;  179 151-157
• 49 Kovacs G, Maier R, Aberer E. et al . Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma.  Am J Respir Crit Care Med. 2009;  180 881-886
• 50 Voelkel M A, Wynne K M, Badesch D B. et al . Hyperuricemia in severe pulmonary hypertension.  Chest. 2000;  117 19-24
• 51 Nagaya N, Nishikimi T, Uematsu M. et al . Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.  Circulation. 2000;  102 865-870
• 52 Williams M H, Handler C E, Akram R. et al . Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.  Eur Heart J. 2006;  27 1485-1494
• 53 Fijalkowska A, Kurzyna M, Torbicki A. et al . Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.  Chest. 2006;  129 1313-1321
• 54 Andreassen A K, Wergeland R, Simonsen S. et al . N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.  Am J Cardiol. 2006;  98 525-529
• 55 Torbicki A, Kurzyna M, Kuca P. et al . Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension.  Circulation. 2003;  108 844-848
• 56 Leuchte H H, Baumgartner R A, Nounou M E. et al . Brain natriuretic peptide is a prognostic parameter in chronic lung disease.  Am J Respir Crit Care Med. 2006;  173 744-750
• 57 McLaughlin V V, McGoon M D. Pulmonary arterial hypertension.  Circulation. 2006;  114 1417-1431
• 58 Eysmann S B, Palevsky H I, Reichek N. et al . Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension.  Circulation. 1989;  80 353-360
• 59 Raymond R J, Hinderliter A L, Willis P W. et al . Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.  J Am Coll Cardiol. 2002;  39 1214-1219
• 60 Forfia P R, Fisher M R, Mathai S C. et al . Tricuspid annular displacement predicts survival in pulmonary hypertension.  Am J Respir Crit Care Med. 2006;  174 1034-1041
• 61 Tei C, Dujardin K S, Hodge D O. et al . Doppler echocardiographic index for assessment of global right ventricular function.  J Am Soc Echocardiogr. 1996;  9 838-847
• 62 Yeo T C, Dujardin K S, Tei C. et al . Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.  Am J Cardiol. 1998;  81 1157-1161
• 63 Nir A, Lindinger A, Rauh M. et al . NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.  Pediatr Cardiol. 2009;  30 3-8
• 64 Koestenberger M, Ravekes W, Everett A D. et al . Right ventricular function in infants, children and adolescents: Reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values.  J Am Soc Echocardiogr. 2009;  22 715-719
• 65 Galie N, Hoeper M M, Humbert M. et al . Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).  Eur Respir J. 2009;  34 1219-1263
• 66 Galie N, Hoeper M M, Humbert M. et al . Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).  Eur Heart J. 2009;  30 2493-2537
• 67 Hoeper M M, Ghofrani H A, Gorenflo M. et al . Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinie 2009.  Pneumologie. 2010;  64 401-414